International Journal of Pharmacology

2005 | 9,241,751 words

The International Journal of Pharmacology (IJP) is a globally peer-reviewed open access journal covering the full spectrum of drug and medicine interactions with biological systems, including chemical, physiological, and behavioral effects across areas such as cardiovascular, neuro-, immuno-, and cellular pharmacology. It features research on drug ...

Metformin Ameliorates Infiltration of Inflammatory Cells and Pancreatic...

Author(s):

Fahaid Al-Hashem
Department of Physiology, College of Medicine, King Khalid University, Abha, Saudi Arabia


Read the Summary


Year: 2022 | Doi: 10.3923/ijp.2022.1038.1046

Copyright (license): Creative Commons Attribution 4.0 International (CC BY 4.0) license.


[Full title: Metformin Ameliorates Infiltration of Inflammatory Cells and Pancreatic Injury Biomarkers Induced by L-Arginine]

[[[ p. 1 ]]]

[[[ p. 2 ]]]

[Summary: This page introduces a study on metformin's effects on L-arginine-induced acute pancreatitis in rats. The study aims to determine if metformin can ameliorate TNF-α-CD45 axis mediated acute pancreatitis by augmenting p-AMPK and inhibiting biomarkers of pancreatic injury. Rats received L-arginine injections, with a protection group pre-treated with metformin.]

OPEN ACCESS International Journal of Pharmacology ISSN 1811-7775 DOI: 10.3923/ijp.2022.1038.1046 Research Article Metformin Ameliorates Infiltration of Inflammatory Cells and Pancreatic Injury Biomarkers Induced by L-Arginine Fahaid Al-Hashem Department of Physiology, College of Medicine, King Khalid University, Abha, Saudi Arabia Abstract Background and Objective: Inflammatory cytokines and leukocytes recruitment to the injury site are involved in the pathogenesis of acute pancreatitis. This study aimed to determine whether metformin can ameliorate TNF- " -CD 45 axis mediated acute pancreatitis associated with the augmentation of p-AMPK and inhibition of biomarkers of acute pancreatic injury. Materials and Methods: The model group of rats received 2 injections of L-arginine (2.5 g kg G 1 ) at 1 hr intervals before being sacrificed after 48 hrs, whereas, the protection group started metformin (50 mg kg G 1 ) treatment daily for 2 weeks before L-arginine injections and continued on metformin until the end of the experiment. Results: L-arginine significantly (p<0.0001) induced inflammation (TNF- " mRNA) and leukocyte recruitment as demonstrated by an increased leukocyte common antigen (CD 45) immunostaining, which was substantially protected by metformin. Metformin also significantly inhibited L-arginine-modulated blood and tissue levels of amylase, LDH, IL-10 mRNA, phosphorylated AMPK. In addition, a significant correlation between the TNF- " -CD 45 axis and biomarkers of acute pancreatitis as well as AMPK, was observed Conclusion: These findings show substantial protection by metformin against L-arginine-induced TNF- " -CD 45 axis mediated acute pancreatitis associated with the upregulation of pancreatic AMPK and down regulation of acute pancreatic injury biomarkers Key words: Acute pancreatitis, inflammation, CD 45, AMPK, IL-10, LDH, metformin Citation: Al-Hashem, F., 2022. Metformin ameliorates infiltration of inflammatory cells and pancreatic injury biomarkers induced by L-arginine. Int. J. Pharmacol., 18: 1038-1046 Corresponding Author: Fahaid Al-Hashem, Department of Physiology, College of Medicine, King Khalid University, Abha 61421, Saudi Arabia Tel: 966-500142929 Copyright: © 2022 Fahaid Al-Hashem. This is an open access article distributed under the terms of the creative commons attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited. Competing Interest: The author has declared that no competing interest exists Data Availability: All relevant data are within the paper and its supporting information files.

[[[ p. 3 ]]]

[Summary: This page discusses acute pancreatitis (AP), a severe inflammatory disease with high mortality. It mentions factors causing AP, like gallstones and alcohol, leading to pancreatic necrosis and leukocyte infiltration. Animal models using L-arginine are valuable for understanding AP and testing treatments. Metformin, an antidiabetic drug, shows promise in ameliorating liver diseases and inhibiting pancreatic cancer. The study investigates metformin's effect on AP in rats. Study details and grouping are described.]

Int. J. Pharmacol.,18 (5): 1038-1046, 2022 INTRODUCTION The inflammatory disease, Acute Pancreatitis (AP) is characterized by severe abdominal pain that lasts for days to a few weeks and represents a significant challenge to the health community since it can develop to systemic inflammation and multiple organs failure causing a high mortality rate that can reach of up to 50% in the severe form of AP 1,2 . The pathogenesis of AP is caused by many factors such as the gallstone blocking the common bile duct, heavy alcohol consumption, adverse drug effects, direct trauma, virus and sepsis and shock 3 . Activation of digestive proteinases like trypsin can lead, in severe cases, to diffuse pancreatic necrosis and haemorrhage, leukocyte infiltration and necrosis and apoptosis of pancreatic acinar cells, which lead to selfdigestion and inflammation of the pancreas 4 . Experimental AP using animal models of the disease is very useful to thoroughly understand the pathophysiology of the disease and to test potential drugs and compounds to treat AP 5 It is well documented that L-arginine can induce AP in rats and mice following intraperitoneal injections of 2 doses (2.5-4 g kg G 1 ) of the amino acid 2,5 . L-arginine is converted to L-citrulline and nitric oxide by the enzyme nitric oxide synthase and the fast reaction of nitric oxide with oxygen radicals yield a highly cytotoxic compound, peroxynitrite that induces nitrosative stress leading to tissue damage 6 . In addition, L-arginine is hydrolyzed to L-ornithine and urea by the enzyme arginase and L-ornithine is reported to induce a severe type of AP in rats 7 . Furthermore, the analogue of the hormone cholecystokinin, cerulean 8 and ethanol 9 were successfully used to induce AP in animal models, which is characterized by pancreatic inflammatory cell infiltration, activation of intracellular digestive enzymes, apoptosis in pancreatic acinar cells, cell death and fibrosis The antidiabetic drug metformin 10 is emerging as a pleiotropic drug that has many benefits. For example, metformin is reported to ameliorate several types of liver diseases such as nonalcoholic fatty liver disease, improving liver injury in diabetes with hyperlipidaemia 11 and protection of primary rat hepatocytes against oxidative stress-induced apoptosis 12 . In addition to the anti-inflammatory 13 and antioxidant 14 effects of metformin, metformin was also reported to inhibit the progression of pancreatic cancer 15 We recently reported inhibition of L-arginine-induced acute pancreatitis by vitamin E via the modulation of TNF- " - AMPK axis 16 and in cell signalling, AMPK activation is the most well-known mechanism of action of the drug metformin 17 Therefore, we speculated that modulation of the TNF- " -CD 45 axis and AMPK by acute pancreatitis in a rat model of the disease could be inhibited with metformin MATERIALS AND METHODS Study area: This study was carried out at the Research Centre, College of Medicine, King Khalid University, Abha, Saudi Arabia from March-June, 2020 Animals: All experimental procedures were approved by the medical research ethical committee at King Khalid University and according to the guide for the care and use of laboratory animals published by the US National Institutes of Health (NIH publication No. 85-23, revised 1996). Male Wistar rats (total 24 rats) weighing 150-200 g were used for these studies. All rats were bred and housed in the research centre of King Khalid University, College of Medicine (Abha, Saudi Arabia), at temperatures of 23±1 E C and a 12 hrs light: 12 hrs dark cycle Rats had free access to tap water and fed standard laboratory chow during the acclimatization period Experimental design: After a 1 week adaptation period, rats were randomly assigned into 4 groups (n = 6, each) and were distributed in their corresponding cages and classified as follows: Control group (Control): Nontreated rats that were injected intraperitoneally with the vehicle, metformin group (Met): Rats treated with metformin (50 mg kg G 1 ) daily for 17 days, L-arginine-treated group, the model group (L-arg): Rats were injected intraperitoneally on day 15 with 2 doses of L-arginine (2.5 g kg G 1 ) at 1 hr intervals 2 . They received no treatment (vehicle) in the 1 st 2 weeks, the protective group (Met +L-arg): Rats were treated with metformin from 1-17 days and injected on day 15 with 2.5 g kg G 1 L-arginine, 2 doses within 1 hr. At the end of the experimental period (on day 17), blood samples were collected by cardiac puncture under anaesthesia (sodium thiopental at 40 mg kg G 1 body weight) and animals were then culled by cervical dislocation under anaesthesia and pancreatic tissues were harvested. Blood samples were collected without anticoagulation, left for 10 min, then centrifuged for 10 min at 4000 r min G 1 to obtain serum, which was stored at -20 E C until further biochemical analysis Determination of blood levels of amylase and lactate dehydrogenase (LDH): On day 17, animals were sacrificed and serum levels of amylase and LDH were assessed (colourimetric) by assay kits obtained from Abcam, Cambridge, UK. All parameters were determined according to the manufacturerʼs instructions Quantitative real-time polymerase chain reaction (qRT-PCR) of TNF- " and IL-10: qRT-PCR was performed as previously 1039

[[[ p. 4 ]]]

[Summary: This page details the methods used, including qRT-PCR for TNF-α and IL-10, Western blotting for AMPK, histological analysis using H&E staining, and immunohistochemistry for CD45 to identify leukocytes. Statistical analysis involved ANOVA and Pearson correlation. Significance was set at p<0.05.]

Int. J. Pharmacol.,18 (5): 1038-1046, 2022 described 13 . In brief, Total RNAs were isolated from freshly dissected ratsʼ pancreases using the RNeasy Mini Kit (Qiagen Pty, Victoria, Australia) and 1 mg RNA was reverse-transcribed with the cDNA synthesis kit (Fermentas, USA). Triplicate cDNA samples and standards were amplified in Master Mix containing SYBR green using an Applied Biosystems (Thermo Fisher Scientific Inc, MA, USA) with primers specific for TNF- " (sense, 5-GATCTCAAAGACAACCAACATGTG-3, antisense, 5-CTC CAGCTGGAAGACTCCTCCCAG-3), IL-10 (sense, 5-GCAGGACTT TAAGGGTTACTTGG-3, antisense, 5-GGGGAGAAATCGATG ACAGC-3) and $ -actin (sense, 5-GGTCGGTGTGAACGGATTTGG- 3, antisense, 5-ATGTAGGCCATGAGGTCCACC-3). The relative expression was calculated according to the manufacturer software Western blotting analysis of AMPK: Proteins were extracted from pancreas tissues and 25 µg of protein per sample were immunoblotted as we described previously 18 . Membranes were probed with anti-AMPK-phospho-Thr 172 (1:1000 Cell Signalling Technology, Beverly, MA, USA) at 4 E C overnight Proteins were visualized using the ECL detection kit (Amersham-Pharmacia, UK). Relative expression was determined using Image analysis software to read the band intensity of the target proteins against the control sample after normalization by $ -actin on the Chemi Doc MP imager Histological analysis: Pancreas specimens were immediately fixed in 10% formal saline for 24 hrs. Paraffin blocks were prepared and 5 µm thick sections were stained with hematoxylin and eosin (H and E) stain to elucidate the status of pancreas architecture and the structural changes Immunohistochemistry of leukocyte common antigen (CD 45): The pancreas from all rats were collected and fixed in 10% formal saline for 24 hrs before dehydration with alcohols and paraffin embedding using standard methods. Blocks were processed, sectioned in 5 µm thickness and deparaffinized. Antigen retrieval was made by boiling the sections in 10 Mm citrate buffer pH 6 for 10 min, then the sections were left to cool at room temperature for 20 min. Sections were incubated in a humidity chamber with the primary antibody, anti-cluster of differentiation (CD) 45 (Cat# ab 10558, Abcam, Cambridge, UK) as a marker for cells of haematopoietic origin. Sections were then counter stained with Meyer hematoxylin Statistical and morphometric analysis: The data were expressed as Mean±Standard Deviation (SD). Data were processed and analyzed using the SPSS version 10.0 (SPSS, Inc., Chicago, Ill., USA). One-way ANOVA was performed followed by Tukeyʼs post hoc test. Pearson correlation statistical analysis was done for the detection of a probable significance between 2 different parameters. Results were considered significant if p<0.05 Using the "Leica Qwin 500 C" image analyzer (Cambridge, UK), the areas (%) of CD 45 immunostaining were obtained in 10 non-overlapping high power fields/rat of immunostained sections. Quantitative data were tabulated as a means and Standard Deviations (SD) and compared using analysis of variance (ANOVA) followed by post hoc analysis (Tukey test) A significant difference was considered when p<0.05. Calculations were made on SPSS software (version 19) RESULTS L-arg induces acute pancreatitis in rats: We first modelled acute pancreatitis in rats to test our working hypothesis mentioned above. Injection of the model group of rats with 2 doses of L-arginine (2.5 g kg G 1 ) at 1 hr intervals caused after 2 days a sharp increase in biomarkers of pancreas injury and abnormal changes in pancreatic tissue histology (Fig. 1). Significant (p<0.001) high serum levels of amylase and LDH were observed in the model group (L-arg) compared to normal levels in the control group (Fig. 1 a-b). Pancreas sections prepared for H and E staining of L-arg injected rats revealed disorganized lobular architecture with inflammatory infiltration within the Connective Tissue (CT) septa. The acini appear with multiple cytoplasmic vacuolations and pyknotic nuclei. In addition, the presence of congested blood vessels and extravasated blood in between the acini compared to normal structures in the control group (Fig. 1 c-d) Metformin inhibits L-arg-induced biomarkers of inflammation and acute pancreatic injury: To determine whether metformin treatment can inhibit the release of biomarkers of inflammation and pancreas injury, we measured tissue gene expression of TNF- " and IL-10 and serum levels of amylase and LDH in all animal groups (Fig. 2). Metformin treatment significantly (p<0.0265) reduced L-arg-induced the inflammatory biomarker TNF- " (Fig. 2 a) and augmented the pancreatic tissue gene expression of the anti-inflammatory biomarker, IL-10 (Fig. 2 b). Metformin also ameliorated serum amylase (Fig. 2 c) and LDH (Fig. 2 d). In addition, the tissue and blood levels of these parameters in the control metformin group were comparable to the control untreated group. However, the level of TNF- " , IL-10, amylase and LDH in the treated group (Met+L-arg) was significantly (p<0.0424) elevated compared with the control group of rats. This means partial protection by metformin was achieved 1040

[[[ p. 5 ]]]

[Summary: This page presents results showing L-arginine induces acute pancreatitis, indicated by elevated amylase and LDH levels. H&E staining reveals tissue damage. Metformin increases AMPK phosphorylation inhibited by L-arginine, suggesting a protective effect.]

Int. J. Pharmacol.,18 (5): 1038-1046, 2022 Fig. 1(a-d): Induction of acute pancreatitis in rats by L-arg, (a) Blood levels of amylase, (b) LDH were measured at the end of the experiment in the model group (L-arg) compared to the control group rats, (c) H&E stained images (x 200) of harvested tissues of rats from the control group and (d) the model group are visualized using light microscopy Results represent the (Mean±SD), *p = 0.001 versus control, (c and d) H&E stained images (x 200) of harvested tissues obtained from the pancreas. Arrows in (D) point to pyknotic nuclei and the (*) points to the CT septa, H and E: Hematoxylin and eosin, L: Lobules, A: Acini, I: Infiltrated inflammatory cells, b: Basophilic cytoplasm, g: Acidophilic granules, v: Vacuoles, BV: Congested blood vessels and B: Extravasated blood Metformin increases AMPK T 172 phosphorylation inhibited by L-arg: To investigate whether the observed inhibition of TNF- " with metformin treatment shown above was also associated with the modulation of AMPK, we evaluated the pancreatic tissue levels of phosphorylated AMPK (p-AMPK) at T 172 in all animal groups (Fig. 3). A sharp decrease in the expression of the p-AMPK protein was observed in immunoblots of pancreatic tissue samples prepared from the model group (L-arg), which was significantly (p<0.0001) augmented by metformin treatment (Fig. 3 a-b) We further determined the correlation between AMPK scorning and TNF- " and amylase in all animal groups. The data in (Fig. 3 c-d) show a negative correlation between AMPK protein expression and these biomarkers, TNF- " mRNA (r = -0.9033, p<0.0001) and amylase (r =-0.7418, p = 0.0004) Metformin inhibits leukocyte infiltration induced by L-arg in pancreas tissue: To determine whether the activator of AMPK, metformin can effectively reduce pancreatic leukocyte infiltration induced by L-arg intoxication in rats, we assessed the infiltration of inflammatory cells (CD 45+ leukocytes) into the pancreas tissue (Fig. 4). Compared to a weak CD 45 positive immunostained cells in control groups (Fig. 4 a-b), immunohistochemical staining for this biomarker in pancreas sections of the L-arg group showed numerous CD 45 positive cells (Fig. 4 c-d), which were significantly (p<0.0001) inhibited by metformin in the metformin-treated groups (Met+L-arg) (Fig. 4 e-f). Furthermore, quantification of CD 45 positive immunostaining cells (Fig. 4 g) showed effective inhibition of CD 45 by metformin Correlation between pancreatic leukocyte infiltration score and inflammation, AMPK and tissue injury biomarkers: The link between CD 45 score and inflammatory and antiinflammatory biomarkers, AMPK and pancreatic injury biomarker in L-arg-induced acute pancreatitis is shown in 1041 800 600 400 200 0 Control L-arg Serum amylase (U L) G 1 * (a) 400 300 200 100 0 Control L-arg Serum L D H (U L ) G 1 * (b) (c) (d) 50 µm 50 µm

[[[ p. 6 ]]]

[Summary: This page shows metformin inhibits L-arginine-induced inflammation and pancreatic injury biomarkers. TNF-α, IL-10, amylase, and LDH levels are affected. Metformin protects against AMPK inhibition caused by acute pancreatitis, correlating with TNF-α and serum amylase levels.]

Int. J. Pharmacol.,18 (5): 1038-1046, 2022 Fig. 2(a-d): Inhibition of L-arg-induced biomarkers of inflammation and acute pancreatic injury by metformin, (a) pancreas tissue levels of TNF-a, (b) pancreas tissue levels of IL-10, (c) blood levels of amylase, (d) blood LDH were measured at the end of the experiment in all groups of rats Results represent the Mean±SD, presented p-values are all significant, *p < 0.0001 versus control and **p < 0.0265 versus L-arg Fig. 3(a-d): Metformin protects against AMPK inhibition caused by acute pancreatitis, pancreas tissue lysates prepared from all the groups of rats were examined by Western blotting for phospho-AMPK (p-AMPK) (a and b) and $ -actin as a loading control (a), Histograms represent the relative expression of p-AMPK signalling protein is shown (b), (c) significant correlation between p-AMPK versus TNF-amRNA, (d) p-AMPK versus serum amylase Results represent the (Mean±SD), Presented p-values are all significant, *p < 0.0001 versus control, **p < 0.0245 versus L-arg 1042 8 6 4 2 0 * ** * T N F - (relative expression) a (a) 800 600 400 200 0 * ** * Amylase (U L) G 1 ( c) Control L-arg Met+L-arg 1.5 1.0 0.5 0.0 ** ** * IL -10 (relative expression) (b) * 400 300 200 100 0 * ** * (d) LDH (U L ) G 1 Control L-arg Met+L-arg 8 6 4 2 0 T issue T N F - a 0.0 0.5 1.0 1.5 AMPK (c) 1000 800 600 400 200 0 Serum amylase 0.0 0.5 1.0 1.5 AMPK (d) 1.5 1.0 0.5 0.0 * ** * A M P K (relative expression) ( b) Control L-arg Met+L-arg Met - - + + - + - + Met L-arg p-AMPK -actin b (a)

[[[ p. 7 ]]]

[Summary: This page focuses on how metformin inhibits L-arginine-induced CD45 expression, indicating reduced leukocyte infiltration. Immunohistochemistry images and quantitative analysis of CD45 immunostaining are presented, showing a significant reduction with metformin treatment.]

Int. J. Pharmacol.,18 (5): 1038-1046, 2022 Fig. 4(a-g): Metformin inhibits L-arg-induced CD 45 expression, (a and b) Immunohistochemistry of CD 45 of pancreas sections (a,c,e, x 200; b,d,f, x 400) from the control, (c and d) L-arg, (e and f) Met+L-arg groups of rats are depicted. (g) histograms represent the quantitative analysis of CD 45 immunostaining area % in pancreas sections from the above groups Arrows point to positive CD 45-immunostained cells, Presented p values are all significant, *p<0.0001 versus control and **p<0.0245 versus L-arg, CD 45: Cluster of differentiation 45 (leukocyte common antigen) and L-arg: L-arginine and Met: Metformin Fig. 5. A significant correlation between these parameters was observed, CD 45 versus TNF- " (r = 0.911, p<0.0001) (Fig. 5 a), CD 45 versus IL-10 (r = -0.968, p<0.0001) (Fig. 5 b), CD 45 versus AMPK (r = -0.954, p<0.0001) (Fig. 5 c) and CD 45 versus amylase (r = 0.792, p<0.0001) (Fig. 5 d) DISCUSSION This study investigated the TNF- " -CD 45 axis mediated acute pancreatitis and AMPK in a rat model of L-arg-induced acute pancreatitis in the presence and absence of metformin Also, we investigated the link between these parameters as well as pancreatic injury biomarkers. Therefore, we modelled acute pancreatic injury in rats and here we have shown, using western blots, qRT-PCR, blood chemistry and immunohistochemistry staining methods that induction of acute pancreatitis in rats by L-arg caused after 2 days a substantial augmentation of inflammation and leukocyte infiltration (CD 45) and inhibition of pancreatic p-AMPK and anti-inflammatory biomarker IL-10 that was modulated by metformin (Fig. 2-4). In addition, our data demonstrate a significant correlation between these parameters which support the link between the pathophysiology of acute pancreatitis with the TNF- " -CD 45 axis and confirm that metformin is an appropriate drug in pancreatic injury rats. Our results were thus consistent with our working hypothesis mentioned above. These are in agreement with previous reports that demonstrated (i) High serum levels of amylase and LDH are well-known biomarkers of pancreatic injury 19 , (ii) Inflammation is a crucial step in the pathogenesis of acute pancreatitis 18 , (iii) Pancreatitis decreases the tissue levels of AMPK 20 and in cell signalling, AMPK is located downstream 1043 (a) (b) (c) (d) (e) (f) Cd 45 immunostaining area (%) 20 15 10 5 0 * ** * Control L-arg Met+L-arg (g)

[[[ p. 8 ]]]

[Summary: This page discusses the correlation between pancreatic leukocyte infiltration and inflammation markers. A positive correlation is observed between CD45 and TNF-α/serum amylase, while a negative correlation exists between CD45 and IL-10/AMPK. Studies on metformin are cited. Elevated TNF-α, amylase, LDH, and CD45, and inhibited AMPK and IL-10 in L-arg-induced AP were all protected with metformin.]

Int. J. Pharmacol.,18 (5): 1038-1046, 2022 Fig. 5(a-d): Correlation between pancreatic leukocyte infiltration score and inflammation, AMPK and tissue injury biomarkers, degree of leukocyte infiltration measured as CD 45 protein expression in all groups of rats after experiment completion. Positive correlation between CD 5 and tissue TNF- " and serum amylase are shown in (a) and (d), respectively. Whereas, negative correlation between CD 5 and tissue IL-10 and AMPK are shown in (b) and (c), respectively of TNF- " 21 and (iv) TNF- " induces leukocyte transmigration 22 and leukocyte infiltration is documented in acute pancreatitis 23 Beneficial effects of metformin were reported to inhibit the progression of pancreatic cancer in diabetic 24 and nondiabetic patients 15 and in sitagliptin-induced pancreatitis in diabetic rats 25 . These reports are consistent with our data that showed the ability of metformin to treat pancreatic injury However, contrasting reports are in disagreement with our findings. For example, a therapeutic dose of metformin caused acute pancreatitis in (i) An old female patient who had a history of Type 2 Diabetes Mellitus (T 2 DM), ischemic heart disease and previous myocardial infarction 26 and (ii) A young “healthy” male with T 2 DM 27 The direct damaging effects of pancreatic proteinases such as trypsin “overflow” and inflammation are known to be involved in the pathology of acute pancreatitis in humans 3 and animals injected with L-arg 8,28 that lead to tissue necrosis A link between these parameters, inflammation, necrosis and severe acute pancreatitis was documented as demonstrated by the augmentation of the inflammatory cytokine TNF- " and biomarkers of tissue necrosis, amylase and LDH in acute pancreatic injury 29,30 . On the other hand, AMPK and the anti-inflammatory cytokine IL-10 were reported to be ameliorated in patients with severe acute pancreatitis and pancreatic cancer 20,31,32 . Also, the severity of acute pancreatitis is higher in knock-out mice for IL-10 33 . In addition, bilepancreatic duct obstruction-induced acute pancreatitis caused an elevation of pancreatic CD 45 expression and TNF- " production, which were inhibited by the antioxidant, N-acetylcysteine 34 . Furthermore, the anti-inflammatory compound resveratrol was reported to inhibit L-arg-induced acute necrotizing pancreatitis 30 . These reports are in agreement with our findings of elevated levels of TNF- " , amylase and LDH, CD 45 and inhibiting levels of AMPK and IL-10 in L-arg-induced AP, which were all protected with metformin. These results demonstrate in animals that metformin can overcome several of the pathogenic mechanisms associated with AP, which show the possibility that metformin has the potential to be further investigated as a therapeutic agent for AP CONCLUSION Collectively, our data support the conclusion that the antidiabetic and anti-inflammatory drug, metformin inhibits 1044 1000 800 600 400 200 0 (d) Serum amylase 0 5 15 10 20 CD 45 8 6 4 2 0 T issue T N F - a (a) 1.5 1.0 0.5 0.0 T issue IL -10 (b) 1.5 1.0 0.5 0.0 AMPK (c) 0 5 15 10 20 CD 45

[[[ p. 9 ]]]

[Summary: This page concludes that metformin inhibits inflammatory cell infiltration and ameliorates pancreatic injury biomarkers in L-arginine-induced acute pancreatitis in rats. It also augments AMPK levels. The study highlights metformin's protective effects on the TNF-α-CD45 axis and AMPK inhibition. A significant correlation between leukocyte infiltration and inflammation is shown. The authors acknowledge support from King Khalid University.]

Int. J. Pharmacol.,18 (5): 1038-1046, 2022 the infiltration of inflammatory cells into the pancreas and also ameliorates biomarkers of pancreatic injury for 17 days in a rat model of acute pancreatitis induced by L-arg. In addition, metformin augments AMPK levels in pancreatic tissue. We also demonstrated an association between these parameters as well as the pancreas injury biomarker SIGNIFICANCE STATEMENT This study represents a significant contribution in the study of acute pancreatic injury induced by L-arginine (L-arg) in rats since it demonstrates that (i) L-arg-induced Acute Pancreatitis (AP) modulated pancreatic TNF- " -CD 45 axis that was protected with metformin, (ii) Metformin protects against AMPK inhibition induced by L-arg and (iii) A significant correlation between leukocyte infiltrations measured as CD 5 protein expression and inflammation, AMPK and pancreatic injury ACKNOWLEDGMENTS This work was supported by the Research Deanship of King Khalid University, Abha, Saudi Arabia; Grant number KKU-Project No. R.G.P 1./44/42. The author would like to thank Professor Bahjat Al-Ani from the Department of Physiology, College of Medicine, King Khalid University, Abha, Saudi Arabia, Professor Mohamed A. Haidara and Dr. Samaa S Kamar from the Physiology and Medical Histology Departments, Kasr Al-Aini Faculty of Medicine, Cairo University, Cairo, Egypt for their input and help during the preparation of this manuscript. We are also grateful to Dr Mariam Al-Ani from Face Studio Clinic, 273 Hagley Road, Birmingham, B 16 9 NB, UK for proofreading the manuscript REFERENCES 1 Leach, S.D., I.M. Modlin, G.A. Scheele and F.S. Gorelick, 1991 Intracellular activation of digestive zymogens in rat pancreatic acini. Stimulation by high doses of cholecystokinin. J. Clin. Invest., 87: 362-366 2 Czakó, L., T. Takács, I.S. Varga, D.Q. Hai and L. Tiszlavicz et al ., 2000. The pathogenesis of L-arginine-induced acute necrotizing pancreatitis: Inflammatory mediators and endogenous cholecystokinin. J. Physiol. Paris, 94: 43-50 3 Cho, J.H., T.N. Kim and S.B. Kim, 2015. Comparison of clinical course and outcome of acute pancreatitis according to the two main etiologies: Alcohol and gallstone. BMC Gastroenterol., Vol. 15. 10.1186/s 12876-015-0323-1 4 Ceppa, E.P., V. Lyo, E.F. Grady, W. Knecht and S. Grahn et al ., 2011. Serine proteases mediate inflammatory pain in acute pancreatitis. Am. J. Physiol. Gastrointestinal Liver Physiol., 300: G 1033-G 1042 5 Kui, B., Z. Balla, B. Vasas, E.T. Végh and P. Pallagi et al ., 2015 New insights into the methodology of L-arginine-induced acute pancreatitis. PLoS ONE, Vol. 10. 10.1371/journal. pone.0117588 6 Venardos, K., W.Z. Zhang, C. Lang and D.M. Kaye, 2009. Effect of peroxynitrite on endothelial L-arginine transport and metabolism. Int. J. Biochem. Cell Biol., 41: 2522-2527 7 Biczó, G., P. Hegyi, S. Berczi, S. Dósa and Z. Hracskó et al ., 2010 Inhibition of arginase activity ameliorates L-arginine-induced acute pancreatitis in rats. Pancreas, 39: 868-874 8 Kim, H., 2008. Cerulein pancreatitis: Oxidative stress, inflammation and apoptosis. Gut Liver, 2: 74-80 9 Pandol, S.J., I. Gukovsky, A. Satoh, A. Lugea and A.S. Gukovskaya, 2003. Animal and in vitro models of alcoholic pancreatitis: Role of cholecystokinin. Pancreas, 27: 297-300 10. Cicero, A.F.G., E. Tartagni and S. Ertek, 2012. Management of diabetic patients with hypoglycemic agents metformin and its clinical use: New insights for an old drug in clinical practice. Arch. Med. Sci., 8: 907-917 11. Matafome, P., T. Louro, L. Rodrigues, J. Crisostomo and E. Nunes et al , 2011. Metformin and atorvastatin combination further protect the liver in type 2 diabetes with hyperlipidaemia. Diabetes/Metab. Res. Rev., 27: 54-62 12. De la Rosa, L.C., T.E. Vrenken, M. Buist-Homan, K.N. Faber and H. Moshage, 2015. Metformin protects primary rat hepatocytes against oxidative stress-induced apoptosis. Pharmacol. Res. Perspect., Vol. 3. 10.1002/prp 2.125 13. Al-Hashem, F., S. Al Humayed, S.N. Amin, S.S. Kamar and S.S. Mansy et al ., 2019. Metformin inhibits mTOR-HIF 1 " axis and profibrogenic and inflammatory biomarkers in thioacetamide-induced hepatic tissue alterations. J. Cell. Physiol., 234: 9328-9337 14. Dallak, M., M.A. Haidara, I. Bin-Jaliah, R.A. Eid, S.N. Amin, N.S.A. Latif and B. Al-Ani, 2019. Metformin suppresses aortic ultrastrucural damage and hypertension induced by diabetes: A potential role of advanced glycation end products. Ultrastructural Pathol., 43: 190-198 15. Li, X., T. Li, Z. Liu, S. Gou and C. Wang, 2017. The effect of metformin on survival of patients with pancreatic cancer: A meta-analysis. Sci. Rep., Vol. 7. 10.1038/s 41598-017-06207-x 16. Al-Hashem, F., M.A. Ellatif, A.M. ShamsEldeen, S.S. Kamar, B. Al-Ani and M.A. Haidara, 2020. Vitamin E protects against the modulation of TNF- " -AMPK axis and inhibits pancreas injury in a rat model of L-arginine-induced acute necrotising pancreatitis. Arch. Physiol. Biochem., 10.1080/13813455. 2020.1806330 1045

[[[ p. 10 ]]]

[Summary: This page lists references for the study. Citations include research on acute pancreatitis, metformin, inflammation, and related topics. References span from 1991 to 2022.]

Int. J. Pharmacol.,18 (5): 1038-1046, 2022 17. Hawley, S.A., A.E. Gadalla, G.S. Olsen and D.G. Hardie, 2002 The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotideindependent mechanism. Diabetes, 51: 2420-2425 18. Al-Ani, B., P.W. Hewett, M.J. Cudmore, T. Fujisawa and M. Saifeddine et al ., 2010. Activation of proteinase-activated receptor 2 stimulates soluble vascular endothelial growth factor receptor 1 release via epidermal growth factor receptor transactivation in endothelial cells. Hypertension, 55: 689-697 19. Matull, W.R., S.P. Pereira and J.W. O'Donohue, 2006 Biochemical markers of acute pancreatitis. J. Clin. Pathol., 59: 340-344 20. Yang, J., Y. Zhou and J. Shi, 2020. Cordycepin protects against acute pancreatitis by modulating NF- κ B and NLRP 3 inflammasome activation via AMPK. Life Sci., Vol. 251. 10.101 6/j.lfs.2020.117645 21. Lv, Q., Q. Zhen, L. Liu, R. Gao and S. Yang et al ., 2015 AMP-kinase pathway is involved in tumor necrosis factor alpha-induced lipid accumulation in human hepatoma cells Life Sci., 131: 23-29 22. Chandrasekharan, U.M., M. Siemionow, M. Unsal, L. Yang and E. Poptic et al ., 2007. Tumor necrosis factor " (TNF- " ) receptor-II is required for TNF- " -induced leukocyteendothelial interaction in vivo . Blood, 109: 1938-1944 23. Ramudo, L., S. Yubero, M.A. Manso, J.S. Recio, E. Weruaga and I. de Dios, 2010. Effect of dexamethasone on peripheral blood leukocyte immune response in bilepancreatic duct obstruction-induced acute pancreatitis Steroids, 75: 362-367 24. Wang, Z., S.T. Lai, L. Xie, J.D. Zhao and N.Y. Ma et al ., 2014 Metformin is associated with reduced risk of pancreatic cancer in patients with type 2 diabetes mellitus: A systematic review and meta-analysis. Diabetes Res. Clin. Pract., 106: 19-26 25. Murad, H.A.S., H.A. Saleh, G.S. Abdulaziz, M.A. Abdulsattar and S.S. Ali, 2015. Effect of metformin and pioglitazone on $ -catenin and biochemical markers in sitagliptin-induced pancreatitis in diabetic rats. Int. J. Diabetes Dev. Ctries., 35: 332-339 26. Mallick, S., 2004. Metformin induced acute pancreatitis precipitated by renal failure. Postgraduate Med. J., 80: 239-240 27. Alsubaie, S. and M.H. Almalki, 2013. Metformin induced acute pancreatitis. Dermato-Endocrinology, 5: 317-318 28. Hegyi, P., Z. Rankonczay, R. Sari, C. Gog, J. Lonovics, T. Takacs and L. Czako, 2004. L-arginine induced experimental pancreatitis. World J. Gastroenterol., 10: 2003-2009 29. Rau, B.M., 2007. Predicting severity of acute pancreatitis Curr. Gastroenterol. Rep., 9: 107-115 30. Wang, N., F. Zhang, L. Yang, J. Zou and H. Wang et al ., 2017 Resveratrol protects against L-arginine-induced acute necrotizing pancreatitis in mice by enhancing SIRT 1- mediated deacetylation of p 53 and heat shock factor 1. Int. J Mol. Med., 40: 427-437 31. Ohmoto, K. and S. Yamamoto, 2005. Serum interleukin-6 and interleukin-10 in patients with acute pancreatitis: Cliniclal implications. Hepatogastroenterology, 52: 990-994 32. Chen, K., W. Qian, J. Li, Z. Jiang and L. Cheng et al ., 2017. Loss of AMPK activation promotes the invasion and metastasis of pancreatic cancer through an HSF 1-dependent pathway Mol. Oncol., 11: 1475-1492 33. Demols, A., J.L. Van Laethem, E. Quertinmont, C. Degraef, M. Delhaye, A. Geerts and J. Deviere, 2002. Endogenous interleukin-10 modulates fibrosis and regeneration in experimental chronic pancreatitis. Am. J. Physiol Gastrointestinal Liver Physiol., 282: G 1105-G 1112 34. de Dios, I., L. Ramudo, A.C. García-Montero and M.A. Manso, 2006. Redox-sensitive modulation of CD 45 expression in pancreatic acinar cells during acute pancreatitis. J. Pathol., 210: 234-239 1046

Other Health Sciences Concepts:

[back to top]

Discover the significance of concepts within the article: ‘Metformin Ameliorates Infiltration of Inflammatory Cells and Pancreatic...’. Further sources in the context of Health Sciences might help you critically compare this page with similair documents:

Inflammation, Primer, Protein, Therapeutic agent, Alcohol consumption, Statistical analysis, Control group, Structural change, Data analysis, Shock, Oxidative stress, Animal model, P Value, Pancreatic Cancer, One-way ANOVA, Antidiabetic Drug, SPSS, Heavy alcohol consumption, Anti-inflammatory effect, Mortality Rate, Apoptosis, Antioxidant Effect, Antioxidant, Biochemical analysis, Liver disease, Experimental period, Nitric oxide, Metformin, Hematoxylin and eosin, Pancreatic injury, Systemic inflammation, Adverse drug effect, Acute necrotizing pancreatitis, Histological analysis, Serum, Citrate buffer, Cervical dislocation, L-arginine induced acute pancreatitis, IL-10, Vitamin E, Resveratrol, Wistar rat, Tissue damage, Amylase, Western blotting, Ethanol, Nitric oxide synthase, Cardiac puncture, Serum level, Lactate dehydrogenase (LDH), Immunohistochemistry, L-arginine, Congested blood vessels, Type 2 diabetes mellitus (T2DM), Cytoplasmic vacuolation, Metformin group, Pearson Correlation, Pyknotic nuclei, Potential drug, Humidity chamber, Arginase, Anti-inflammatory drug, Leukocyte infiltration, Pancreatic tissue, Tissue necrosis, Common Bile Duct, QRT-PCR, Anti-inflammatory cytokine, Pathogenic mechanism, Tukey's post-hoc test, Cell signalling, Biomarkers of inflammation, High Power Field, Master mix, Nitrosative stress, SYBR Green, Inflammatory infiltration, Paraffin embedding, Assay kits, Peroxynitrite, Primary antibody, Trypsin, AMPK activation, AMPK, Pancreatic acinar cells, Inflammatory cell, Inflammatory cytokine, Direct trauma, Relative expression, Inflammatory biomarker, ECL detection kit, H and E staining, Hematoxylin and eosin (H and E), Model group, Western blotting analysis, Formal saline, Anti-inflammatory biomarker, P-AMPK, Blood level.

Let's grow together!

I humbly request your help to keep doing what I do best: provide the world with unbiased sources, definitions and images. Your donation direclty influences the quality and quantity of knowledge, wisdom and spiritual insight the world is exposed to.

Let's make the world a better place together!

Like what you read? Help to become even better: